Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of Anti-HCV immunoglobulin G avidity index

Journal of Clinical Microbiology

Volumn 45, Issue 10, 2007, Pages 3400-3403

  Klimashevskaya, S ^a,b   Obriadina, A ^b   Ulanova, T ^b   Bochkova, G ^b   Burkov, A ^b   Araujo, A ^a   Stramer, Susan L ^c   Tobler, Leslie H ^d   Busch, Michael P ^d   Fields, Howard A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RPC Diagnostic Systems   (Russian Federation)

^c AMERICAN RED CROSS   (United States)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G;

ACUTE DISEASE; ARTICLE; CHRONIC DISEASE; CHRONICITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS DIAGNOSIS;

ACUTE DISEASE; ANTIBODY AFFINITY; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; RNA, VIRAL; TIME FACTORS; UREA;

HEPATITIS C VIRUS;

EID: 35348928196     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01012-07     Document Type: Article

References (17)

1. Brillanti, S., C. Masci, P. Ricci, M. Miglioli, and L. Barbara. 1992. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. J. Hepatol. 15:998-1001.
2. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb. Mortal. Wkly. Rep. 47(RR-19):1-39.
3. Chang, J. C., B. Ruedinger, M.-E. Cong, S. Lambert, E. Lopareva, M. Purdy, B. P. Holloway, D. L. Jue, B. Ofenloch, H. A. Fields, and Y. E. Khudyakov. 1999. Artificial NS4 mosaic antigen of hepatitis C virus. J. Med. Virol. 59:437-450.
4. Chau, K. H., G. J. Dawson, I. K. Mushahwar, R. A. Gutierrez, R. G. Johnson, R. R. Lesniewski, L. Mattsson, and O. Weiland. 1991. IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis. J. Virol. Methods 35:343-352.
5. Chen, P. J., J. T. Wang, L. H. Hwang, Y. H. Yang, C. L. Hsieh, J. H. Kao, J. C. Sheu, M. Y. Lai, T. H. Wang, and D. S. Chen. 1992. Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection. Proc. Natl. Acad. Sci. USA 89:5971-5975.
6. de Souza, V. A. U. F., S. Fernandos, E. S. Araujo, A. F. Tateno, O. M. N. P. F. Oliveria, R. D. R. Oliveira, and C. S. Pannuti. 2004. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42:1782-1784.
7. Eisen, H. N., and G. W. Siskind. 1964. Variations in affinities of antibodies during the immune response. Biochemistry 3:996-1008.
8. Gray, J. J., and T. G. Wreghitt. 1989. Immunoglobulin G avidity in Epstein-Barr virus infection in organ transplant recipients. Serodiagn. Immunother. Infect. Dis. 3:389-393.
9. Hedman, K., and I. Seppala. 1988. Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol. 8:214-221.
10. Hofer, H., T. Watkins-Riedel, O. Janata, E. Penner, H. Holzmann, P. Steindl-Munda, A. Gangl, and P. Ferenci. 2003. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 37:60-64.
11. Kanno, A., and Y. Kazuyama. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J. Med. Virol. 68:229-233.
12. Larghi, A., M. Zuin, A. Crosignani, M. L. Ribero, C. Pipia, P. M. Battezzati, G. Binelli, F. Donato, A. R. Zanetti, M. Podda, and A. Tagger. 2002. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 36:993-1000.
13. Lehmann, M., M. F. Meyer, M. Monazahian, H. L. Tillmann, M. P. Manns, and H. Wedemeyer. 2004. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J. Med. Virol. 73:387-391.
14. Lu, S.N., H.-D. Tung, T.-M. Chen, C.-M. Lee, J.-H. Wang, C.-H. Hung, C.-H. Chen, and C.-S. Changchien. 2004. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titer rather than by seroconversion? J. Viral Hepat. 11:563-570.
15. Marcellin, P. 1999. Hepatitis C: the clinical spectrum of the disease. J. Hepatol. 31:9-16.
16. Ward, K. N., W. Dhaliwal, K. L. Ashworth, E. J. Clutterbuck, and C. G. Teo. 1994. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J. Med. Virol. 43:367-372.
17. Wawrzynowicz-Syczewska, M., J. Kubicka, Z. Lewandowski, A. Boron-Kaczmarska, and M. Radkowski. 2004. Natural history of acute symptomatic hepatitis type C. Infection 32:138-143.